¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Oxidative Phosphorylation Coupling Factors"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® phosphorylation ÇÑ±Û ÀλêÈ­
¼³¸í   
  ¾î¶² ¹°Áú¿¡ ÀλêÀÌ ºÙ´Â ¹ÝÀÀ. Àλê±â°¡ È­ÇÕ¹°ÀÇ ±¸¼º¼ººÐÀΠOHÀÇ H¿Í Ä¡È¯µÊÀ¸·Î½á È­ÇÕ¹°¿¡ °áÇÕ(È­ÇÕ) ÇÏ¿© ÀϾ´Ù. Ã´Ãßµ¿¹°ÀÇ ±ÙÀ°Á¶Á÷¿¡¼­ Å©·¹¾ÆÆ¾ÀλêÀÌ »ý¼ºµÇ´Â È­ÇйÝÀÀ¿¡¼­Ã³·³ NHÀÇ H¿Í Ä¡È¯µÇ´Â Á¾·ùµµ ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • oxidative phosphorylation
    »êÈ­ÀλêÈ­
  • phosphorylation
    ÀλêÈ­
  • oxidative
    »êÈ­-
  • oxidative chain
    »êÈ­¿¬¼â
  • oxidative degradation
    »êÈ­ºÐÇØ
  • oxidative enzyme
    »êÈ­È¿¼Ò
  • oxidative fermentation
    »êÈ­¹ßÈ¿
  • oxidative free radical
    »êÈ­ÀÚÀ¯±â, »êÈ­ÀÚÀ¯¶óµðÄ®
  • coupling
    1. ¦ÁöÀ½ 2. °áÇÕ 3. ¿¬°á 4. Ä¿Çøµ
  • coupling color
    Ä¿Çøµ¿°·á
  • coupling interval
    ¿¬°á°£°Ý
  • coupling medium
    °áÇÕ¸ÅÁú
  • chemical coupling
    È­ÇÐÄ¿Çøµ
  • chemiosmotic coupling
    È­ÇлïÅõÄ¿Çøµ
  • direct coupling
    Á÷Á¢¿¬°á, Á÷Á¢°áÇÕ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • coupling
    ¦Áö¿ò, °áÇÕ, ¿¬°á, Ä¿Çøµ
  • oxidative enzyme
    »êÈ­È¿¼Ò
  • phosphorylation
    ÀλêÈ­
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • phosphorylation
    ÀλêÈ­
  • oxidative chain
    »êÈ­¿¬¼â
  • oxidative deamination
    »êÈ­Å»¾Æ¹ÎÈ­
  • oxidative decarboxylation
    »êȭŻź»ê¹ÝÀÀ
  • oxidative degradation
    »êÈ­ºÐÇØ
  • oxidative enzyme
    »êÈ­È¿¼Ò
  • oxidative fermentation
    »êÈ­¹ßÈ¿
  • oxidative
    »êÈ­-
  • oxidative free radical
    »êÈ­ÀÚÀ¯±â
  • coupling
    ¦Áö¿ò, °áÇÕ, ¿¬°á, Ä¿Çøµ
  • chemical coupling
    È­ÇÐÄ¿Çøµ
  • chemiosmotic coupling
    È­ÇлïÅõÄ¿Çøµ
  • coupling color
    Ä¿Çøµ¿°·á
  • coupling interval
    ¿¬°á°£°Ý
  • coupling medium
    °áÇÕ¸ÅÁú
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • phosphogluconate oxidative pathway
    ±Û·çÄÜ»ê»êÈ­°æ·Î, ÀÎ´ç¿ø»êÈ­°æ·Î(ìÝÓØ ê«ß«ûùÌèÖØ).
  • phosphorylation
    ÀλêÈ­(ìÝß«ûù).
  • phosphorylation
    ÀλêÈ­
  • Insulin-like growth factors
    Àν¶¸°¾ç(å×)¼ºÀå(à÷íþ)È£¸£¸ó
  • J-coupling interaction
    J °áÇÕ »óÈ£ÀÛ¿ë
  • J-coupling processe
    J °áÇÕ °úÁ¤
  • acoustic coupling
    À½ÇâÀü´Þ
  • heteronuclear coupling
    ÀÌÇÙ¼º °áÇÕ
  • psychological factors affecting medical condition
    ÀÇÇÐÀû»óÅ¿¡ ¿µÇâÀ» ÁÖ´Â ½É¸®Àû ¿ä¼Ò.
  • psychological factors affecting physical condition
    ½Åü»óÅ¿¡ ¿µÇâÀ» ÁÖ´Â ½É¸®Àû ¿ä¼Ò.
  • quality factors
    Ư¼º ¿ä¼Ò, Áú ¿ä¼Ò
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • oxidative phosphorylation
    »êÈ­Àû ÀλêÈ­
  • oxidative phosphorylation
    »êÈ­Àû ÀλêÈ­
  • oxidative phosphorylation
    »êÈ­Àû ÀλêÈ­ (¡­ìÝß«ûù).
  • oxidative phosphorylation
    »êÈ­¼º ÀλêÈ­
  • coupling medium ; coupling agent ; couplant
    Àü´Þ¸ÅÁú.
  • phosphorylation
    ÀλêÈ­
  • phosphorylation
    ÀλêÈ­(ìÝß«ûù).
  • substrate level phosphorylation
    ±âÁú±Þ ÀλêÈ­.
  • coagulation factors
    ÀÀ°íÀÎÀÚ(¡­ì×í­)
  • exogenous factors
    ¿ÜÀμº ¿ä¼Ò(èâì×àõ é©áÈ).
  • exogenous factors
    ¿ÜÀμº ¿ä¼Ò(¡­é©áÈ).
  • factors
  • psychological factors affecting medical condition
    ÀÇÇÐÀû»óÅ¿¡ ¿µÇâÀ» ÁÖ´Â ½É¸®Àû ¿ä¼Ò.
  • psychological factors affecting physical condition
    ½Åü»óÅ¿¡ ¿µÇâÀ» ÁÖ´Â ½É¸®Àû ¿ä¼Ò.
  • quality factors
    Ư¼º ¿ä¼Ò, Áú ¿ä¼Ò
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • oxidative phosphorylation
    »êÈ­Àû ÀλêÈ­(ß«ûùîÜ×òß«ûù)
  • fibroblast growth factors
    ¼¶À¯¾Æ¼¼Æ÷ ¼ºÀÚÀÎÀÚ (àéë«ä´á¬øàà÷íþì×í­)
  • suppressor factors
    ¾ï¾Ð(ÀÚ) ÀÎÀÚ(åääâ(í­)ì×í­)
  • hexose monophosphate oxidative pathway
    ÀÏÀλê(ìé×òß«) Çí¼Ò½º »êÈ­°æ·Î (ß«ûùÌèÖØ)
  • oxidative assimilation
    »êÈ­Àû µ¿È­(ß«ûùîÜÔÒûù)
  • oxidative deamination
    »êÈ­Àû Å»(÷­)¾Æ¹ÎÈ­(ûù)
  • phosphogluconate oxidative pathway
    Æ÷½ºÆ÷±Û·çÄÜ»ê(ß«) »êÈ­°æ·Î(ß«ûùÌèÖØ)
  • phosphorylation
    ÀλêÈ­(×òß«ûù)
  • phosphorylation potential
    ÀλêÈ­ ÀüÀ§(×òß«ûùï³êÈ)
  • photosynthetic phosphorylation
    ±¤ÇÕ¼º ÀλêÈ­(×òß«ûù)
  • respiratory chain phosphorylation
    È£Èí¿¬¼â ÀλêÈ­(×òß«ûù)
  • substrate phosphorylation
    ±âÁú ÀλêÈ­ (Ðñòõ×òß«ûù)
  • vectorial phosphorylation
    ÁöÇâ(ò¦ú¾) ÀλêÈ­(×òß«ûù)
  • biochemical coupling hypothesis
    »ýÈ­ÇÐÀû(ßæûùùÊîÜ) ¦ÁöÀ½¼³(àã)
  • chemical coupling hypothesis
    È­ÇÐ(ûùùÊ) Ä«Çøµ¼³(àã)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • oxidative free radical
    »êÈ­ÀÚÀ¯±â
  • quality factors
    Ư¼º¿ä¼Ò, Áú¿ä¼Ò
  • coupling
    °áÇÕ
  • coupling medium
    °áÇÕ¸ÅÁú, Àü´Þ¸ÅÁú
  • dipole dipole coupling dynamic
    ½Ö±ØÀÚ½Ö±ØÀÚ¿ªµ¿Àû°áÇÕ
  • electromagnetic coupling
    ÀüÀڷ¿¬°è
  • exchange coupling
    ±³È¯°áÇÕ
  • heteronuclear coupling
    ÀÌÇÙ¼º°áÇÕ
  • J-coupling interaction
    J°áÇÕ»óÈ£ÀÛ¿ë
  • J-coupling processe
    J°áÇÕ°úÁ¤
  • spin spin coupling
    ½ºÇɽºÇÉÄ¿Çøµ
  • spin spin coupling constant (J)
    ½ºÇɽºÇÉÄ¿Çøµ»ó¼ö (J)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
FOG fast oxidative glycolytic [fiber]
CF calcaneal fibular [ligament]; calcium leucovorin; calf blood flow; calibration factor; cancer-free; ...
F0, F1 coupling factor
ANF Atrial Natriuretic Factors
ECF   1) Eosinophilic Chemotatic Factors
  2) Extra-Cellular Fluid; ¼¼Æ÷ ¿Ü¾×
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
OXPHOS Oxidative phosphorylation
E-C coupling Excitation-contraction coupling
PTP Protein tyrosine phosphorylation
CF1 Coupling Factor 1
ECC Excitation-contraction coupling
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • oxidative phosphorylation
    »êÈ­Àû ÀλêÈ­
  • controlling factors in facial growth
    ¾È¸é ¼ºÀåÀÇ Á¶Àý ¿äÀÎ
  • substrate level phosphorylation
    ±âÁú±Þ ÀλêÈ­
  • acoustic coupling
    À½Çâ Àü´Þ
  • chemical coupling
    È­ÇÐÀû Ä«Çøµ
  • coupling agent
    °áÇÕÁ¦, Ä¿ÇøµÁ¦
    ·¹Áø ±âÁú°ú ÇÊ·¯ÀÇ »çÀÌ¿¡ Á¸ÀçÇÏ¿© ¾çÀÚ¸¦ È­ÇÐÀûÀ¸·Î °áÇÕ½Ã۰í, Á¢Âø È¿°ú¸¦ ³ôÀÌ´Â ¹°Áú. ÀϹÝÀûÀ¸·Î ½Ç¶õÁ¦°¡ ÀÌ¿ëµÇ°í ÀÖ´Ù.
  • coupling factor
    ¹è¿ì ÀÎÀÚ
  • silane coupling agent
    ½Ç¶õÄ¿ÇÁ¸µÁ¦
    ±âÀç¿Í ÇÊ·¯ÀÇ »çÀÌ¿¡ À־ ¾çÀÚ¸¦ È­ÇÐÀûÀ¸·Î °áÇÕÇϰí Á¢Âø È¿°ú¸¦ ³ôÀ̴µ¥ »ç¿ëµÇ´Â ½Ç¶õÁ¦.
  • spin spin coupling
    ½ºÇÉ ½ºÇÉ Ä¿Çøµ, ½ºÇÉ ½ºÇÉ Â¦Áö¿ò, ½ºÇÉ ½ºÇÉ °áÇÕ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
oxidative phosphorylation <biochemistry> The phosphorylation of ATP coupled to the respiratory chain.
(18 Nov 1997)
coupling factors Proteins that restore phosphorylating ability to mitochondria that have lost it, i.e., have become "uncoupled" so that oxidation and electron transport no longer produces ATP. Usually termed coupling factor F1, F2, etc.
Synonym: C factors.
(05 Mar 2000)
magnesium protoporphyrin monomethyl ester oxidative cyclase <enzyme> In chlorophyll biosynthesis converts -(ch2)2-coo-ch3 side chain of mg protoporphyrin monomethyl ester to -c=o-ch-cooch3 ring of mg 2,4-divinyl phaeoporphyrin a(5) monomethyl ester; requires NADPH and molecular oxygen; similar to cytochrome p-450 catalyzed systems but not inhibited by co
Registry number: EC 1.14.13.-
Synonym: mpme-oxidative cyclase
(26 Jun 1999)
phosphorylation <biochemistry> The creation of a phosphate derivative of an organic molecule. This isusually achieved by transferring a phosphate group from ATP.
(09 Oct 1997)
phosphorylation of proteins <biochemistry> Addition of phosphate groups to hydroxyl groups on proteins (side chains s, T or Y) catalysed by a protein kinase often specific) with ATP as phosphate donor. Activity of proteins is often regulated by phosphorylation.
(18 Nov 1997)
mitochondrial oxidative damage endonuclease <enzyme> An 8-oxog-specific DNA endonuclease from rat liver mitochondria; recognises and incises at 8-oxog and abasic acid sites in duplex DNA
Registry number: EC 3.1.25.-
Synonym: oxidative damage-specific endonuclease, mtode enzyme
(26 Jun 1999)
cyclic phosphorylation Any process in which a phosphatide ester forms a cylic diester by linkage to a neighbouring hydroxyl group.
(18 Nov 1997)
substrate-level phosphorylation Synthesis of high-energy phosphate bonds through reaction of inorganic phosphate with an activated (usually) organic substrate.
(09 Oct 1997)
oxidative Having the power to oxidise; denoting a process involving oxidation.
(05 Mar 2000)
oxidative metabolism Respiration in the biochemical sense.
(18 Nov 1997)
oxidative stress A highly oxidized environment within cells that is thought to promote HIV replication because cells are forced into a highly activated state due to loss of control of their regulatory systems.
(09 Oct 1997)
electron transport phosphorylation <biochemistry> Synthesis of ATP involving a membrane associated electron transport chain and the creation of a proton-motive force.
(09 Oct 1997)
tyrosine phosphorylation <enzyme> Kinases that phosphorylate protein tyrosine residues. These kinases play major roles in mitogenic signalling and can be divided into two subfamilies: receptor tyrosine kinases, that have an extracellular ligand binding domain, a single transmembrane domain and an intracellular tyrosine kinase domain and nonreceptor tyrosine kinases, which are soluble, cytoplasmic kinases.
(18 Nov 1997)
lactic acid oxidative decarboxylase A flavoprotein oxidoreductase catalyzing oxidation (with O2) of l-lactate to acetate plus CO2 and water.
Synonym: lactic acid oxidative decarboxylase.
(05 Mar 2000)
viscous mechanical coupling <cell biology> Method by which adjacent cilia are synchronised in a field. Coupling is through the transmission of mechanical forces, rather than of a synchronising signal.
(18 Nov 1997)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 1 ÆäÀÌÁö: 1
  • Oxidative Phosphorylation Coupling Factors - »õâ
    Synonyms :
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • oxidative
    »êÈ­ÀÇ;»êÈ­·ÂÀÌ ÀÖ´Â
  • coupling
    ¿¬°á
  • chain coupling
    »ç½½ ¿¬°á±â
  • coupling
    ¿¬°á;°áÇÕ;±³¹Ì;(öµµÂ÷·®ÀÇ)¿¬°á±â(ÀåÄ¡);Ä¿Çøµ;¿¬°á±â(ÀåÄ¡)
  • friction coupling
    ¸¶Âû Á¢ÇÕ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á